Hyperfine, Inc. Receives Nasdaq Notice for Possible Delisting (Low Bid Price)

What Happened
Hyperfine, Inc. (HYPR) filed an 8-K reporting that on September 17, 2026 Nasdaq’s Listing Qualifications Department notified the company it no longer meets the minimum $1.00 closing bid price requirement after the stock traded below $1.00 for 30 consecutive business days. The notice does not affect current listing or trading—HYPR continues to trade on The Nasdaq Global Market under the ticker "HYPR"—and does not change the company’s SEC reporting obligations.

Key Details

• Notice date: September 17, 2026; 8-K filed September 18, 2026 (Item 3.01).
• Deficiency: closing bid price < $1.00 for 30 consecutive business days, violating Nasdaq Listing Rule 5450(a)(1).
• Cure period: initial 180-calendar-day compliance period under Nasdaq Rule 5810(c)(3)(A), ending March 16, 2027. To regain compliance the closing bid must be ≥ $1.00 for at least 10 consecutive business days.
• If not cured, the company may seek an additional 180-day period by transferring to The Nasdaq Capital Market and meeting other initial listing standards (except the bid-price test), possibly using measures such as a reverse stock split; if delisting is determined, Hyperfine can appeal to a Nasdaq Hearings Panel.

Why It Matters
A continued failure to meet Nasdaq’s $1.00 bid-price standard could lead to delisting, which can reduce liquidity, limit investor access, and negatively affect shareholder value. For now, trading and operations are unchanged, but investors should monitor the stock’s closing price, company communications about potential remedies (e.g., reverse stock split), and any further Nasdaq notices or appeals.